English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Ureteric stents are commonly used in urological practice (Mohan-Pillai et al., 1999). They were first described in 1967 by Zimskind et al. (Zimskind et al., 1967). Ureteric stents are used after treatment of kidney and ureteric stones, for relieving renal obstructions and after urological procedures such as kidney transplantation, ureteric stricture (Soylu et al., 2007). However, complications such as stent obstruction, migration and encrustation, biofilm and stone formation may occur (Lojanapiwat, 2005).

The Effect of Oral Co-trimoxazole on Decreasing Bacterial Adherence and Biofilm Formation on Ureteral Stents Surfaces